financetom
Business
financetom
/
Business
/
Why Is Nauticus Robotics Stock Down 20% Today?
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Why Is Nauticus Robotics Stock Down 20% Today?
Mar 11, 2026 7:36 AM

Nauticus Robotics Inc ( KITT ) shares are trading lower Wednesday morning after the marine robotics company disclosed a new convertible debt issuance that could add to future share dilution. Here’s what investors need to know.

Nauticus Robotics ( KITT ) stock is feeling bearish pressure. What’s pressuring KITT stock?

Nauticus Issues $1 Million Convertible Note Due 2026

In a Form 8-K filed with the SEC, Nauticus said it issued an original issue discount senior secured convertible debenture due 2026 with an aggregate principal amount of about $1.02 million to an institutional investor.

The note is convertible into 1,717,281 common shares at a conversion price of $0.5942 per share and matures on Sept. 9, 2026, unless repaid earlier under its terms.

The company said the new note was issued under a securities purchase agreement dated Nov. 4, 2024, and carries the same terms as prior notes issued under that arrangement.

Convertible Note Raises Dilution Concerns

Investors often view convertible financings cautiously because they can pressure existing shareholders by increasing the potential number of shares outstanding.

The market reaction suggests traders are focused on that dilution risk, even though the financing provides Nauticus with additional capital as it continues executing its underwater robotics business strategy.

KITT Shares Plunge Wednesday Morning

KITT Price Action: Nauticus Robotics ( KITT ) shares were down 20.59% at $0.80 at the time of publication on Wednesday. The stock is trading near its 52-week low of $0.66, according to Benzinga Pro data.

Image: Shutterstock

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
US fund association picks new board as risks loom of higher tax, new regulations
US fund association picks new board as risks loom of higher tax, new regulations
Oct 2, 2024
NEW YORK (Reuters) - The Managed Funds Association, an alternative asset management trade group, announced on Wednesday its new board of directors, as well as its chair Jody Gunderson, managing principal at $16 billion credit investment firm AB CarVal, as the industry prepares for the threat of higher taxes and new regulation. The new team comes as the advocacy group...
Foran Mining Closes US$250 Million Upsized Project Finance Credit Facility
Foran Mining Closes US$250 Million Upsized Project Finance Credit Facility
Oct 2, 2024
07:09 AM EDT, 10/02/2024 (MT Newswires) -- Foran Mining ( FMCXF ) on Wednesday said it has closed an upsized US$250 million senior secured project credit facility with a fund managed by Sprott Resource Lending. The non-revolving facility has a maturity date of Sept. 30, 2031. The credit facility amends and restates the company's original US$150 million senior secured project...
Correction: Market Chatter: Apple to Launch New iPhone SE, iPad Air Models in Early 2025
Correction: Market Chatter: Apple to Launch New iPhone SE, iPad Air Models in Early 2025
Oct 2, 2024
07:11 AM EDT, 10/02/2024 (MT Newswires) -- (Corrects the targeted year of launch in the headline.) Apple ( AAPL ) is readying production of a new iPhone SE that will be its latest entry-level model and will debut early next year, Bloomberg reported Tuesday, citing people with knowledge of the matter. The company also plans to release new iPad Air...
Vera Therapeutics Expands Development of Kidney Disease Drug Pipeline
Vera Therapeutics Expands Development of Kidney Disease Drug Pipeline
Oct 2, 2024
07:08 AM EDT, 10/02/2024 (MT Newswires) -- Vera Therapeutics ( VERA ) said Wednesday that it would expand the development of its lead asset, atacicept, following positive results from the ongoing phase 2 and 3 trials in patients with IgA nephropathy and other autoimmune kidney indications. The company said it plans to initiate a study in Q4 to give its...
Copyright 2023-2026 - www.financetom.com All Rights Reserved